Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates

Maria Rosalia Pasca, Claudia Dalla Valle, Ana Luisa De Jesus Lopes Ribeiro, Silvia Buroni, Maria Cristiana Papaleo, Silvia Bazzini, Claudia Udine, Maria Loreto Incandela, Silvio Daffara, Renato Fani, Giovanna Riccardi, Piero Marone

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Efflux transporters have a considerable role in the multidrug resistance (MDR) of Pseudomonas aeruginosa, an important nosocomial pathogen. In this study, 45 P. aeruginosa clinical strains, with an MDR phenotype, have been isolated in a hospital of Northern Italy and characterized to identify the mechanisms responsible for their fluoroquinolone (FQ) resistance. These isolates were analyzed for clonal similarity, mutations in genes encoding the FQ targets, overexpression of specific Resistance Nodulation-cell Division efflux pumps, and search for mutations in their regulatory genes. The achieved results suggested that the mutations in genes encoding ciprofloxacin targets represented the main mechanism of FQ resistance of these strains; 97.8% of these isolates showed mutations in gyrA, 28.9% in gyrB, 88.9% in parC, and 6.7% in parE. Another mechanism of resistance was overexpression of the efflux pumps in some representative strains. In particular, overexpression of MexXY-OprM drug transporter was found in five isolates, whereas overexpression of MexCD-OprJ was detected in two isolates; surprisingly, in one of these last two isolates, also overexpression of MexAB-OprM pump was identified.

Original languageEnglish
Pages (from-to)23-32
Number of pages10
JournalMicrobial Drug Resistance
Volume18
Issue number1
DOIs
Publication statusPublished - Feb 1 2012

Fingerprint

Fluoroquinolones
Multiple Drug Resistance
Pseudomonas aeruginosa
Mutation
Regulator Genes
Ciprofloxacin
Cell Division
Italy
Genes
Phenotype
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology
  • Immunology
  • Microbiology

Cite this

Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates. / Pasca, Maria Rosalia; Dalla Valle, Claudia; De Jesus Lopes Ribeiro, Ana Luisa; Buroni, Silvia; Papaleo, Maria Cristiana; Bazzini, Silvia; Udine, Claudia; Incandela, Maria Loreto; Daffara, Silvio; Fani, Renato; Riccardi, Giovanna; Marone, Piero.

In: Microbial Drug Resistance, Vol. 18, No. 1, 01.02.2012, p. 23-32.

Research output: Contribution to journalArticle

Pasca, MR, Dalla Valle, C, De Jesus Lopes Ribeiro, AL, Buroni, S, Papaleo, MC, Bazzini, S, Udine, C, Incandela, ML, Daffara, S, Fani, R, Riccardi, G & Marone, P 2012, 'Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates', Microbial Drug Resistance, vol. 18, no. 1, pp. 23-32. https://doi.org/10.1089/mdr.2011.0019
Pasca, Maria Rosalia ; Dalla Valle, Claudia ; De Jesus Lopes Ribeiro, Ana Luisa ; Buroni, Silvia ; Papaleo, Maria Cristiana ; Bazzini, Silvia ; Udine, Claudia ; Incandela, Maria Loreto ; Daffara, Silvio ; Fani, Renato ; Riccardi, Giovanna ; Marone, Piero. / Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates. In: Microbial Drug Resistance. 2012 ; Vol. 18, No. 1. pp. 23-32.
@article{0af701517cf74ed99d7ada7d55bb8825,
title = "Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates",
abstract = "Efflux transporters have a considerable role in the multidrug resistance (MDR) of Pseudomonas aeruginosa, an important nosocomial pathogen. In this study, 45 P. aeruginosa clinical strains, with an MDR phenotype, have been isolated in a hospital of Northern Italy and characterized to identify the mechanisms responsible for their fluoroquinolone (FQ) resistance. These isolates were analyzed for clonal similarity, mutations in genes encoding the FQ targets, overexpression of specific Resistance Nodulation-cell Division efflux pumps, and search for mutations in their regulatory genes. The achieved results suggested that the mutations in genes encoding ciprofloxacin targets represented the main mechanism of FQ resistance of these strains; 97.8{\%} of these isolates showed mutations in gyrA, 28.9{\%} in gyrB, 88.9{\%} in parC, and 6.7{\%} in parE. Another mechanism of resistance was overexpression of the efflux pumps in some representative strains. In particular, overexpression of MexXY-OprM drug transporter was found in five isolates, whereas overexpression of MexCD-OprJ was detected in two isolates; surprisingly, in one of these last two isolates, also overexpression of MexAB-OprM pump was identified.",
author = "Pasca, {Maria Rosalia} and {Dalla Valle}, Claudia and {De Jesus Lopes Ribeiro}, {Ana Luisa} and Silvia Buroni and Papaleo, {Maria Cristiana} and Silvia Bazzini and Claudia Udine and Incandela, {Maria Loreto} and Silvio Daffara and Renato Fani and Giovanna Riccardi and Piero Marone",
year = "2012",
month = "2",
day = "1",
doi = "10.1089/mdr.2011.0019",
language = "English",
volume = "18",
pages = "23--32",
journal = "Microbial Drug Resistance",
issn = "1076-6294",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates

AU - Pasca, Maria Rosalia

AU - Dalla Valle, Claudia

AU - De Jesus Lopes Ribeiro, Ana Luisa

AU - Buroni, Silvia

AU - Papaleo, Maria Cristiana

AU - Bazzini, Silvia

AU - Udine, Claudia

AU - Incandela, Maria Loreto

AU - Daffara, Silvio

AU - Fani, Renato

AU - Riccardi, Giovanna

AU - Marone, Piero

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Efflux transporters have a considerable role in the multidrug resistance (MDR) of Pseudomonas aeruginosa, an important nosocomial pathogen. In this study, 45 P. aeruginosa clinical strains, with an MDR phenotype, have been isolated in a hospital of Northern Italy and characterized to identify the mechanisms responsible for their fluoroquinolone (FQ) resistance. These isolates were analyzed for clonal similarity, mutations in genes encoding the FQ targets, overexpression of specific Resistance Nodulation-cell Division efflux pumps, and search for mutations in their regulatory genes. The achieved results suggested that the mutations in genes encoding ciprofloxacin targets represented the main mechanism of FQ resistance of these strains; 97.8% of these isolates showed mutations in gyrA, 28.9% in gyrB, 88.9% in parC, and 6.7% in parE. Another mechanism of resistance was overexpression of the efflux pumps in some representative strains. In particular, overexpression of MexXY-OprM drug transporter was found in five isolates, whereas overexpression of MexCD-OprJ was detected in two isolates; surprisingly, in one of these last two isolates, also overexpression of MexAB-OprM pump was identified.

AB - Efflux transporters have a considerable role in the multidrug resistance (MDR) of Pseudomonas aeruginosa, an important nosocomial pathogen. In this study, 45 P. aeruginosa clinical strains, with an MDR phenotype, have been isolated in a hospital of Northern Italy and characterized to identify the mechanisms responsible for their fluoroquinolone (FQ) resistance. These isolates were analyzed for clonal similarity, mutations in genes encoding the FQ targets, overexpression of specific Resistance Nodulation-cell Division efflux pumps, and search for mutations in their regulatory genes. The achieved results suggested that the mutations in genes encoding ciprofloxacin targets represented the main mechanism of FQ resistance of these strains; 97.8% of these isolates showed mutations in gyrA, 28.9% in gyrB, 88.9% in parC, and 6.7% in parE. Another mechanism of resistance was overexpression of the efflux pumps in some representative strains. In particular, overexpression of MexXY-OprM drug transporter was found in five isolates, whereas overexpression of MexCD-OprJ was detected in two isolates; surprisingly, in one of these last two isolates, also overexpression of MexAB-OprM pump was identified.

UR - http://www.scopus.com/inward/record.url?scp=84856707767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856707767&partnerID=8YFLogxK

U2 - 10.1089/mdr.2011.0019

DO - 10.1089/mdr.2011.0019

M3 - Article

C2 - 21797666

AN - SCOPUS:84856707767

VL - 18

SP - 23

EP - 32

JO - Microbial Drug Resistance

JF - Microbial Drug Resistance

SN - 1076-6294

IS - 1

ER -